| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.887 | 42.032 | 108.833 | 137.012 | 50.916 | 47.111 | 10.622 | 0 | 16.173 | 0 |
| Total Income - EUR | 45.887 | 42.034 | 108.835 | 137.012 | 50.947 | 47.111 | 11.625 | 3.763 | 32.752 | 0 |
| Total Expenses - EUR | 14.555 | 10.896 | 69.071 | 59.609 | 10.779 | 17.551 | 19.742 | 28.194 | 16.678 | 345 |
| Gross Profit/Loss - EUR | 31.333 | 31.137 | 39.764 | 77.403 | 40.168 | 29.560 | -8.117 | -24.431 | 16.074 | -345 |
| Net Profit/Loss - EUR | 29.956 | 30.297 | 38.676 | 76.033 | 39.659 | 29.115 | -8.234 | -24.431 | 14.581 | -345 |
| Employees | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Cebis Medical Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.016 | 0 | 19.308 |
| Current Assets | 18.775 | 31.119 | 88.622 | 201.262 | 112.685 | 191.654 | 68.749 | 50.377 | 71.724 | 546 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 17.998 | 3.494 | 88.531 | 199.108 | 111.329 | 185.335 | 68.478 | 49.922 | 71.404 | 173 |
| Cash | 777 | 27.625 | 91 | 2.154 | 1.356 | 6.318 | 270 | 454 | 320 | 373 |
| Shareholders Funds | 18.190 | 30.508 | 39.864 | 115.165 | 39.887 | 68.246 | 58.498 | 34.249 | 54.735 | -128 |
| Social Capital | 56 | 200 | 197 | 193 | 190 | 186 | 182 | 183 | 182 | 181 |
| Debts | 584 | 611 | 48.758 | 86.097 | 72.798 | 123.408 | 10.250 | 16.128 | 16.990 | 19.982 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.016 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Cebis Medical Research Srl